TST-808

N/A

Report date: 2026/01/05 17:19:23

Base Information

Drug NameTST-808
Drug Alias NameTST808TST-808
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionTumor necrosis factor ligand superfamily member 13 modulators
TargetsTumor necrosis factor ligand superfamily member 13
Therapy Area/IndicationsAutoimmune DiseasesGlomerulonephritis, IGA
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesTranscenta Holding Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTranscenta Holding Ltd
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesGlomerulonephritis, IGA
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A